Premorbid functioning in schizophrenia spectrum disorders with comorbid substance use: A systematic review
Premorbid functioning has been related with several clinical features and prognosis of schizophrenia spectrum disorders. Comorbidity with substance use is highly prevalent and usually hinders clinical improvement in this kind of psychiatric disorders. This systematic review analyzes the differences...
| Autores: | , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2021 |
| País: | España |
| Institución: | Universidad de Barcelona |
| Repositorio: | Dipòsit Digital de la UB |
| OAI Identifier: | oai:diposit.ub.edu:2445/185538 |
| Acceso en línea: | https://hdl.handle.net/2445/185538 |
| Access Level: | acceso abierto |
| Palabra clave: | Esquizofrènia Abús de substàncies Ressenyes sistemàtiques (Investigació mèdica) Schizophrenia Substance abuse Systematic reviews (Medical research) |
| id |
ES_8ee69c74e5e2fb885117bdaaede7d445 |
|---|---|
| oai_identifier_str |
oai:diposit.ub.edu:2445/185538 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Premorbid functioning in schizophrenia spectrum disorders with comorbid substance use: A systematic reviewPrat, GemmaMarquez Arrico, Julia E.Río Martínez, LauraNavarro Humanes, José FranciscoAdan Puig, AnaEsquizofrèniaAbús de substànciesRessenyes sistemàtiques (Investigació mèdica)SchizophreniaSubstance abuseSystematic reviews (Medical research)Premorbid functioning has been related with several clinical features and prognosis of schizophrenia spectrum disorders. Comorbidity with substance use is highly prevalent and usually hinders clinical improvement in this kind of psychiatric disorders. This systematic review analyzes the differences in the premorbid functioning of subjects with a schizophrenia spectrum disorder with substance use (SSD+, dual psychosis) or without it (SSD-). A systematic review (PRISMA guidelines), including search in electronic databases (MEDLINE, Web of Science, and Cochrane Library), was performed. 118 published works were considered of which only 20 met our inclusion criteria. Although there is a great variability in methodologies, diagnoses included, and substances used, studies using the Premorbid Functioning Scale to assess the academic and/or social domains found that SSD+ subjects had a poorer academic but better social premorbid functioning than those with SSD-. Current evidence is not conclusive, so additional studies are required to integrate intervening factors in order to clarify the clinical implications of premorbid functioning to improve the course and therapeutic response of patients.Elsevier B.V.2021info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://hdl.handle.net/2445/185538Articles publicats en revistes (Psicologia Clínica i Psicobiologia)reponame:Dipòsit Digital de la UBinstname:Universidad de BarcelonaInglésReproducció del document publicat a: https://doi.org/10.1016/j.pnpbp.2021.110310Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2021, vol. 110, p. 110310https://doi.org/10.1016/j.pnpbp.2021.110310cc-by (c) Prat et al., 2021https://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:diposit.ub.edu:2445/1855382026-05-27T06:46:51Z |
| dc.title.none.fl_str_mv |
Premorbid functioning in schizophrenia spectrum disorders with comorbid substance use: A systematic review |
| title |
Premorbid functioning in schizophrenia spectrum disorders with comorbid substance use: A systematic review |
| spellingShingle |
Premorbid functioning in schizophrenia spectrum disorders with comorbid substance use: A systematic review Prat, Gemma Esquizofrènia Abús de substàncies Ressenyes sistemàtiques (Investigació mèdica) Schizophrenia Substance abuse Systematic reviews (Medical research) |
| title_short |
Premorbid functioning in schizophrenia spectrum disorders with comorbid substance use: A systematic review |
| title_full |
Premorbid functioning in schizophrenia spectrum disorders with comorbid substance use: A systematic review |
| title_fullStr |
Premorbid functioning in schizophrenia spectrum disorders with comorbid substance use: A systematic review |
| title_full_unstemmed |
Premorbid functioning in schizophrenia spectrum disorders with comorbid substance use: A systematic review |
| title_sort |
Premorbid functioning in schizophrenia spectrum disorders with comorbid substance use: A systematic review |
| dc.creator.none.fl_str_mv |
Prat, Gemma Marquez Arrico, Julia E. Río Martínez, Laura Navarro Humanes, José Francisco Adan Puig, Ana |
| author |
Prat, Gemma |
| author_facet |
Prat, Gemma Marquez Arrico, Julia E. Río Martínez, Laura Navarro Humanes, José Francisco Adan Puig, Ana |
| author_role |
author |
| author2 |
Marquez Arrico, Julia E. Río Martínez, Laura Navarro Humanes, José Francisco Adan Puig, Ana |
| author2_role |
author author author author |
| dc.subject.none.fl_str_mv |
Esquizofrènia Abús de substàncies Ressenyes sistemàtiques (Investigació mèdica) Schizophrenia Substance abuse Systematic reviews (Medical research) |
| topic |
Esquizofrènia Abús de substàncies Ressenyes sistemàtiques (Investigació mèdica) Schizophrenia Substance abuse Systematic reviews (Medical research) |
| description |
Premorbid functioning has been related with several clinical features and prognosis of schizophrenia spectrum disorders. Comorbidity with substance use is highly prevalent and usually hinders clinical improvement in this kind of psychiatric disorders. This systematic review analyzes the differences in the premorbid functioning of subjects with a schizophrenia spectrum disorder with substance use (SSD+, dual psychosis) or without it (SSD-). A systematic review (PRISMA guidelines), including search in electronic databases (MEDLINE, Web of Science, and Cochrane Library), was performed. 118 published works were considered of which only 20 met our inclusion criteria. Although there is a great variability in methodologies, diagnoses included, and substances used, studies using the Premorbid Functioning Scale to assess the academic and/or social domains found that SSD+ subjects had a poorer academic but better social premorbid functioning than those with SSD-. Current evidence is not conclusive, so additional studies are required to integrate intervening factors in order to clarify the clinical implications of premorbid functioning to improve the course and therapeutic response of patients. |
| publishDate |
2021 |
| dc.date.none.fl_str_mv |
2021 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://hdl.handle.net/2445/185538 |
| url |
https://hdl.handle.net/2445/185538 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
Reproducció del document publicat a: https://doi.org/10.1016/j.pnpbp.2021.110310 Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2021, vol. 110, p. 110310 https://doi.org/10.1016/j.pnpbp.2021.110310 |
| dc.rights.none.fl_str_mv |
cc-by (c) Prat et al., 2021 https://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
cc-by (c) Prat et al., 2021 https://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Elsevier B.V. |
| publisher.none.fl_str_mv |
Elsevier B.V. |
| dc.source.none.fl_str_mv |
Articles publicats en revistes (Psicologia Clínica i Psicobiologia) reponame:Dipòsit Digital de la UB instname:Universidad de Barcelona |
| instname_str |
Universidad de Barcelona |
| reponame_str |
Dipòsit Digital de la UB |
| collection |
Dipòsit Digital de la UB |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869413167196536832 |
| score |
15.300719 |